Shares of Snowflake Inc (NYSE:SNOW) rose sharply in pre-market trading after the company posted upbeat financial results for the second quarter.

Snowflake reported second-quarter revenue of $1.55 billion, beating analyst estimates of $1.48 billion, according to Benzinga Pro. The AI data cloud company reported adjusted earnings of 62 cents per share for the quarter, beating estimates of 45 cents per share.

Snowflake shares jumped 24.3% to $380.00 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • Generation Income Properties Inc (NASDAQ:GIPR) gained 48.2% to $0.58 in pre-market trading after rising 8% on Wednesday.
  • BioXcel Therapeutics Inc (NASDAQ:BTAI) rose 32.7% to $0.14 in pre-market trading after dipping 22% on Wednesday. BioXcel Therapeutics recently announced it filed for Chapter 11 Bankruptcy.
  • Tillys Inc (NYSE:TLYS) rose 25.7% to $4.79 in pre-market trading after the retailer reported second-quarter results that beat its outlook and showed continued double-digit comparable sales growth.
  • Gelteq Ltd (NASDAQ:GELS) gained 21.2% to $0.85 in pre-market trading after jumping over 30% on Wednesday.
  • Mint Incorporation Ltd (NASDAQ:MIMI) rose 20.1% to $0.77 in pre-market trading after declining 10% on Wednesday.
  • ChargePoint Holdings Inc (NYSE:CHPT) gained 18.7% to $6.16 in pre-market trading after the company reported better-than-expected second-quarter financial results.
  • HUTCHMED (China) Ltd (NASDAQ:HCM) rose 18.7% to $14.29 in pre-market trading after the company announced a licensing agreement with GSK for KRAS-EGFR-antibody conjugate cancer therapy.
  • GoPro Inc (NASDAQ:GPRO) shares gained 11.3% to $1.88 in pre-market trading after jumping 37% on Wednesday. GoPro recently announced it entered into a definitive merger agreement with Starman Optical in a $285 million deal.
  • Petco Health and Wellness Company Inc (NASDAQ:WOOF) rose 9.5% to $2.88 in pre-market trading after the company reported better-than-expected quarterly EPS results

Losers

  • Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) tumbled 45.4% to $14.48 in pre-market trading after the company announced results from the Phase 3 Aspire study for apazunersen did not achieve the primary endpoint of change from Baseline in Bayley-4 cognitive raw score nor the key secondary endpoint of net response in Multidomain Responder Index.
  • Gix Internet Ltd. (NASDAQ:GIXI) fell 25.1% to $8.99 in pre-market trading after jumping 41% on Wednesday.
  • BioRestorative Therapies, Inc. (NASDAQ:BRTX) fell 15.7% to $0.17 in pre-market trading. BioRestorative Therapies announced a 1-for-20 reverse stock split.
  • Zeo Energy Corp. (NASDAQ:ZEO) declined 11.4% to $0.1991 in pre-market trading after gaining 7% on Wednesday.
  • Scinai Immunotherapeutics Ltd (NASDAQ:SCNI) fell 12.4% to $2.05 in pre-market trading after declining 5% on Wednesday.
  • Advasa Holdings, Inc. (NASDAQ:ADBT) fell 11.5% to $1.5203 in pre-market trading. Advasa Holdings shares dipped 53% on Wednesday after the company announced the resignation of its CFO Katharyn Field.
  • Methode Electronics, Inc. (NYSE:MEI) fell 10% to $16.24 in pre-market trading after the company reported mixed quarterly financial results.
  • NetApp, Inc. (NASDAQ:NTAP) fell 8.2% to $165.97 in pre-market trading following first-quarter results.
  • SL Science Holding Limited (NASDAQ:SLBT) fell 7% to $3.08 in pre-market trading after jumping over 18% on Wednesday.
  • Trip.com Group Limited (NASDAQ:TCOM) fell 4.5% to $41.65 in pre-market trading. Trip.com Group will report second quarter and first half of 2026 financial results on Sept. 15.

Photo via Shutterstock